|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/70 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| A61K 31/445 | (2006.01) | ||
| A61K 31/46 | (2006.01) | ||
| A61K 47/10 | (2006.01) | ||
| A61K 47/14 | (2006.01) | ||
| A61P 5/30 | (2006.01) |
| (11) | Number of the document | 1229909 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01939751.2 |
| Date of filing the European patent application | 2001-05-31 | |
| (97) | Date of publication of the European application | 2002-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2003-11-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US0117/567 |
| Date | 2001-05-31 |
| (87) | Number | WO 0109/1724 |
| Date | 2001-12-06 |
| (30) | Number | Date | Country code |
| 208789 P | 2000-06-01 | US |
| (72) |
FIKSTAD, David, US
QUAN, Danyi, US
|
| (73) |
Watson Pharmaceuticals, Inc.,
311 Bonnie Circle, Corona, CA 92880,
US
|
| (54) | TRANSDERMAL DELIVERY OF LASOFOXIFENE |
| TRANSDERMAL DELIVERY OF LASOFOXIFENE |